2018
DOI: 10.1101/389858
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

The Network of Cancer Genes (NCG): a comprehensive catalogue of known and candidate cancer genes from cancer sequencing screens

Abstract: The Network of Cancer Genes (NCG) is a manually curated repository of 2,372 genes whose somatic modifications have a known or predicted cancer driver role.These genes were collected from 275 publications, including two sources of known cancer genes and 273 cancer sequencing screens of 119 cancer types in 31 primary sites from 34,905 cancer donors. This represents a more than 1.5-fold increase in content as compared to the previous version. NCG also annotates properties of cancer genes, such as duplicability, e… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
65
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 45 publications
(66 citation statements)
references
References 60 publications
0
65
0
Order By: Relevance
“…Known cancer genes (Repana et al , ) that are located on the same cytogenetic bands as the olfactory receptors in our metagene were retrieved. To test whether the olfactory receptor metagene can predict survival independent of the expression of neighbouring cancer genes Cox proportional hazard test was performed (Table EV9).…”
Section: Methodsmentioning
confidence: 99%
“…Known cancer genes (Repana et al , ) that are located on the same cytogenetic bands as the olfactory receptors in our metagene were retrieved. To test whether the olfactory receptor metagene can predict survival independent of the expression of neighbouring cancer genes Cox proportional hazard test was performed (Table EV9).…”
Section: Methodsmentioning
confidence: 99%
“…Reports of cases of RCC with a constitutional chromosome rearrangement were identified through a search of PubMed using the search terms “renal cell carcinoma” or “renal cancer” or “kidney cancer/tumor” and “rearrangement/inversion/translocation or chromosome” and by searching of previously published reports (performed January 2019). When previous reports had suggested candidate genes that were either close to or disrupted by the relevant chromosomal breakpoints, evidence to suggest that the genes were implicated in human cancer was sought by reviewing curated data from the Network of Cancer Genes data portal (NCG; http://ncg.kcl.ac.uk/ version 6) (performed January 2019) where genes were classified as either “known cancer genes,” “candidate cancer genes,” or “non‐cancer genes.” Genes flagged as “false positive cancer genes” were designated as “non‐cancer genes.”…”
Section: Methodsmentioning
confidence: 99%
“…The corresponding TADs were then intersected with the genomic positions of all known gene loci (Supporting Information) to find genes contained within a given TAD and only protein‐coding genes were included. Protein‐coding genes identified within a TAD were assessed for potential function in cancer using the Network of Cancer Genes data portal (NCG; http://ncg.kcl.ac.uk/ version 6), as previously described. TAD regions were visualized using the Hi‐C data browser (http://promoter.bx.psu.edu/hi-c/index.html).…”
Section: Methodsmentioning
confidence: 99%
“…Fusion transcript calls were contrasted with genomic SV data and visually verified on DNA level using IGV. Rearranged genes implicated in cancer were identified using the Network of Cancer Genes 6.0 (NCG 6.0) and literature search.…”
Section: Methodsmentioning
confidence: 99%